乳腺癌髓系来源抑制细胞中IDO对T淋巴细胞免疫抑制作用初探

杨宝宏 于津浦 李慧 任宝柱 刘俊田 安秀梅 刘婷 任秀宝

杨宝宏, 于津浦, 李慧, 任宝柱, 刘俊田, 安秀梅, 刘婷, 任秀宝. 乳腺癌髓系来源抑制细胞中IDO对T淋巴细胞免疫抑制作用初探[J]. 中国肿瘤临床, 2012, 39(9): 506-509. doi: 10.3969/j.issn.1000-8179.2012.09.007
引用本文: 杨宝宏, 于津浦, 李慧, 任宝柱, 刘俊田, 安秀梅, 刘婷, 任秀宝. 乳腺癌髓系来源抑制细胞中IDO对T淋巴细胞免疫抑制作用初探[J]. 中国肿瘤临床, 2012, 39(9): 506-509. doi: 10.3969/j.issn.1000-8179.2012.09.007
Baohong YANG, Jinpu YU, Hui LI, Baozhu REN, Juntian LIU, Xiumei AN, Ting LIU, Xiubao REN. Immunosuppressive Impact of IDO on T Cells in MDSCs of Breast Cancer[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2012, 39(9): 506-509. doi: 10.3969/j.issn.1000-8179.2012.09.007
Citation: Baohong YANG, Jinpu YU, Hui LI, Baozhu REN, Juntian LIU, Xiumei AN, Ting LIU, Xiubao REN. Immunosuppressive Impact of IDO on T Cells in MDSCs of Breast Cancer[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2012, 39(9): 506-509. doi: 10.3969/j.issn.1000-8179.2012.09.007

乳腺癌髓系来源抑制细胞中IDO对T淋巴细胞免疫抑制作用初探

doi: 10.3969/j.issn.1000-8179.2012.09.007
详细信息
    通讯作者:

    任秀宝  rwziyi@yahoo.com

Immunosuppressive Impact of IDO on T Cells in MDSCs of Breast Cancer

More Information
  • 摘要:   目的   检测乳腺癌患者肿瘤原位组织的一群髓系来源抑制细胞(MDSCs)中吲哚胺2,3双加氧酶(indoleamine-2,3-dioxygenase,IDO)的表达情况,探讨IDO对MDSCs介导T淋巴细胞免疫抑制作用的影响。   方法   收集30例乳腺癌患者的肿瘤组织和外周血及30例健康供者外周血,将肿瘤组织制成单细胞悬液,采用免疫磁珠技术分选肿瘤单细胞悬液中CD33+ MDSCs和健康供者外周血中的CD33+细胞,应用Western blot和PCR方法检测MDSCs中IDO的表达情况。将肿瘤组织来源MDSCs和异体T淋巴细胞按照1:1比例混合培养3天,在加用和不加IDO特异性抑制剂1-MT条件下,利用Annexin-V凋亡试剂盒检测各组T淋巴细胞凋亡率,利用ELISA法检测各组T淋巴细胞分泌的细胞因子量。   结果   Western blot和PCR检测发现MDSCs中IDO过表达。T细胞单独培养时凋亡率为(2.40±0.66)%,MDSCs和T细胞共孵育组中T细胞凋亡率为(12.30±0.80)%,比T细胞单独培养时显著升高(P < 0.05),在共孵育过程中加用1-MT组的T细胞凋亡率为(3.30±0.58)%,与不加1-MT组比较差异具有统计学意义(P < 0.05)。细胞因子检测的结果发现MDSCs促进T淋巴细胞TGF-β、IL-10的释放,抑制IFN-γ的分泌,而对IL-4和IL-12的分泌影响并不明显,而加用1-MT后MDSCs和T淋巴细胞共孵育组中TGF-β、IL-10的分泌水平与未加1-MT组相比显著降低,IFN-γ的分泌显著增加(P < 0.05)。   结论   在乳腺癌患者中,原位肿瘤组织来源的MDSCs对T细胞具有明显的免疫抑制作用;IDO在此群细胞中有过表达,MDSCs发挥免疫抑制作用与IDO密切相关。

     

  • 图  1  利用磁珠分选后进行流式检测乳腺癌患者肿瘤单细胞悬液中Lin1-CD45+CD33+CD13+CD14-CD15-所占比例

    A:对照组; B:正常人外周血MDSC所占比例; C:乳腺癌患者外周血MDSC所占比例; D:乳腺癌患者肿瘤单细胞悬液中MDSC所占比例

    Figure  1.  Percentage of MDSC in breast cancer after magnetic cell sorting

    图  2  Western blot(A)和PCR(B)检测MDSC上IDO的表达

    M:Marker;1:β-actin;2:对照组IDO;3:实验组IDO

    Figure  2.  Measurement of IDO expression by MDSC through Western blot and PCR

    图  3  MDSCs诱导T细胞凋亡

    A:对照组;B:T淋巴细胞单独培养组;C:MDSC+T组;D:MDSC+T+1-MT组

    Figure  3.  MDSC-induced apoptosis of T cells

    图  4  T细胞在不同组中的凋亡

    Figure  4.  Apoptosis of T cells in different groups

    图  5  与MDSC共孵育的淋巴细胞分泌细胞因子水平

    Figure  5.  Cytokine fluctuations when T lymphocytes were incubated with MDSC

  • [1] Srivastava MK, Sinha P, clements VK, et al. Myeloid-derived suppressor cells inhibit T-cell activation by dePleting cystine and cysteine[J]. Cancer Res, 2010, 70(1): 68-77. doi: 10.1158/0008-5472.CAN-09-2587
    [2] Hanson EM, Clements VK, Sinha P, et al. Myeloid-derived suPPressor cells down-regulate L-selectin exPression on CD4 + and CD8+ T cells[J]. J Immvnol, 2009, 183(2): 937-944. doi: 10.4049/jimmunol.0804253
    [3] Delano MJ, ScumPia PO, Weinstein JS, et al. MyD88-dePendent exPansion of an immature GR-1(+)CD11b(+)PoPulation induces T cell suPPression and Th2 Polarization in sePsis[J]. J Exp Med, 2007, 204(6): 1463-1474. doi: 10.1084/jem.20062602
    [4] Gabrilovich DI, Bronte V, Chen SH, et al. The terminology issue for myeloid-derived suPPressor cells[J]. Cancer Res, 2007, 67(1): 425-426. doi: 10.1158/0008-5472.CAN-06-3037
    [5] Kusmartsev S, Cheng F, Yu B, et al. All-trans-retinoic acid eliminates immature myeloid cells from tumor-bearing mice and imProves the effect of vaccination[J]. Cancer Res, 2003, 63(15): 4441-4449. http://www.researchgate.net/profile/Sergei_Kusmartsev/publication/10621821_All-_trans_-Retinoic_Acid_Eliminates_Immature_Myeloid_Cells_from_Tumor-bearing_Mice_and_Improves_the_Effect_of_Vaccination/links/0c96051826f87d104e000000.pdf
    [6] Makarenkova VP, Bansal V, Matta BM, et al. CD11b+/Gr-1+ myeloid suPPressor cells cause T cell dysfunction after traumatic stress [J]. J Immunol, 2006, 176(4): 2085-2094. doi: 10.4049/jimmunol.176.4.2085
    [7] Rodriguez PC, Ochoa AC. T cell dysfunction in cancer: role of myeloid cells and tumor cells regulating amino acid availability and oxidative stress[J]. Semin Cancer Biol, 2006, 16(1): 66-72. doi: 10.1016/j.semcancer.2005.10.001
    [8] 沈春, 于津浦, 李慧, 等. 乳腺癌患者髓系来源抑制性细胞的鉴定与免疫抑制作用研究[J]. 中国肿瘤临床, 2009, 36(17): 1010-1015. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGZL200917017.htm
    [9] Sinha P, Clements VK, Bunt SK, et al. Cross-talk between myeloid-derived suPPressor cells and macroPhages subverts tumor immunity toward a tyPe 2 resPonse[J]. J Immunol, 2007, 179(2): 977-983. doi: 10.4049/jimmunol.179.2.977
    [10] Movahedi K, Guilliams M, Van den Bossche J, et al. Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity[J]. Blood, 2008, 111(8): 4233-4244. doi: 10.1182/blood-2007-07-099226
    [11] Zhu B, Bando Y, Xiao S, et al. CD11b + Ly-6C(hi) suPPressive monocytes in exPerimental autoimmune encePhalomyelitis[J]. J Immunol, 2007, 179(8): 5228-5237. doi: 10.4049/jimmunol.179.8.5228
  • 加载中
图(5)
计量
  • 文章访问数:  55
  • HTML全文浏览量:  1
  • PDF下载量:  1
  • 被引次数: 0
出版历程
  • 收稿日期:  2012-02-01
  • 修回日期:  2012-04-26

目录

    /

    返回文章
    返回